Drexel University

The postholder will lead the initial development of a report and evidence portfolio that will help to inform a Horticultural Strategy for Northern Ireland as part of the Maximising UK Adaptation to Climate Change (MACC) Hub, funded by NERC and DEFRA. The post holder will design and facilitate a structured programme of stakeholder engagement across Northern Ireland's horticultural sector, drawing on the Three Horizons framework to identify shared visions, barriers, and transition pathways for climate-adapted food production. The post is hosted within the Co-Centre for Climate, Biodiversity and Water at Queen's University Belfast and will work in close partnership with the Climate NI Team at Northern Ireland Environment Link (NIEL) and the MACC Hub coordination team, contributing to climate adaptation-focused knowledge sprints across all four jurisdictions of the UK. About the person The successful candidate must have, and your application should clearly demonstrate that you meet the following essential criteria: Have or be about to obtain* a relevant PhD in a discipline related to food systems, agri-food geography, rural sociology, environmental science, ecology, agriculture, horticulture or closely related field (*must be obtained within 3 months of commencement of employment). Demonstrable experience of planning and delivering participatory or stakeholder engagement research, including workshop facilitation with diverse groups. Experience of applying qualitative or mixed-methods research approaches to food systems, agricultural transition, community development, or environmental management. Ability to synthesise complex, multisource evidence into clear, policy-relevant outputs. To be successful at shortlisting stage, please ensure you clearly evidence in your application how you meet the essential and, where applicable, desirable criteria listed in the Candidate Information on our website. This post is available for 12 months or until 21 November 2027, whichever is soonest. Fixed term contract posts are available for the stated period in the first instance but in particular circumstances may be renewed or made permanent subject to availability of funding. What we offer Beyond a competitive salary, the University offers an attractive benefits package including a holiday entitlement of up to 8.4 weeks a year, pension schemes and development opportunities. We support staff wellbeing with flexible working options, work-life balance initiatives and support for physical and mental health. You can find more detail on all of this and more on our website. Queen's University is committed to promoting equality of opportunity to all. We subscribe to Equality Charter Marks such as the Diversity Charter Mark NI and Athena Swan and have established staff networks such as iRise (Black, Asian, Minority Ethnic and International Staff Network) and PRISM (LGBTQ+) which help us progress equality. For further information on our commitment to Equality, Diversity and Inclusion, please visit our website. If you are an international applicant and don't already hold a visa that permits you to take up the role you are applying for, please use the information provided on our website to self-assess whether the University is likely to be able to support a visa application.

ImmunoViroTherapy Lab at the Faculty of Pharmacy, University of Helsinki, invites applications for the position of a DOCTORAL RESEARCHER (Generation and optimization of armed oncolytic viruses (e.g. rADV-IL-12 variants) for treatment of GBM, DC 2 in MSCA-DN INTRABRAIN) for a full-time position funded for three years. Earliest starting date is in September 2026, with the exact starting date negotiable after selection. Position Description Prof. Vincenzo Cerullo’s lab is seeking a PhD student to validate novel recombinant armed oncolytic virus variants as potential therapeutic agents for glioblastoma (GBM). The selected PhD candidate will obtain degree at the University of Helsinki. The PhD position consists of studies at Faculty of Pharmacy, University of Helsinki (UH, Finland) and secondments at consortium partner organisations in Italy, Spain and France. The position is funded by the Doctoral Network (DN) project “INTRABRAIN” of the Horizon-Marie Skłodowska-Curie Actions (MSCA). The topics of the PhD candidate: The doctoral candidate will focus on developing and validating novel rADV-IL-12 variants as potential therapeutic agents for glioblastoma (GBM). Their work will involve generating recombinant oncolytic adenoviruses, evaluating their efficacy through in vitro and in vivo experiments, and analysing the immune response and antigenic profile of treated tumours. In addition, the candidate will contribute to scaling up the most promising viral constructs from laboratory research to production-ready systems. Through secondments they will gain expertise in intranasal delivery strategies, focused ultrasound technologies for enhancing drug delivery across the blood–brain barrier and nanomaterial integration. The candidate will also address technical challenges related to viral vector design and delivery by applying advanced (bio)nanotechnology-based solutions. INTRABRAIN Project Description The INTRABRAIN project is an ambitious and highly innovative research and training initiative aimed at revolutionising the treatment of glioblastoma multiforme (GBM) through next-generation cancer immunotherapy. By integrating cutting-edge nanotechnology, virotherapy and immunology, the project focuses on developing novel therapeutic strategies based on polymeric nanoparticles delivering engineered oncolytic adenoviruses encoding the immune-stimulating cytokines. This approach is designed to overcome major clinical challenges such as the blood–brain barrier and tumour-induced immunosuppression, enabling targeted, efficient and less invasive treatment via intranasal delivery. In parallel, INTRABRAIN fosters the training of a new generation of highly skilled doctoral researchers through interdisciplinary, intersectoral and international collaboration, equipping them with advanced scientific and transferable skills. Overall, the project aims not only to advance groundbreaking therapeutic solutions but also to contribute significantly to the future of personalised cancer medicine and biomedical innovation in Europe. Requirements To be a doctoral candidate (DC): You must, at the time of recruitment, be in the first four years (full-time equivalent) of your research career and have not been awarded a doctoral degree. Full-time equivalent research experience is measured from the date when you obtained the degree, which formally entitles you to embark on a doctorate, either in the country in which the degree was obtained or in the country in which the research training is provided, irrespective of whether or not a doctorate was envisaged. Mobility rule: At the time of the recruitment, you must not have resided or carried out your main activity (e.g. work and studies) in Finland for more than 12 months in the 3 years immediately prior to your recruitment. Short stays, such as holidays, are not taken into account. English language: Network fellows (DCs) must demonstrate that their ability to understand and express themselves in both written and spoken English is sufficiently high for them to derive the full benefit from the network training. Master level in Pharmaceutical Sciences, Biotechnology, Molecular Biology, Biomedical Engineering, Nanomedicine, Pharmacy, Pharmaceutical Chemistry and Technology, or related field, ideally with a multidisciplinary background in molecular biology, immunology and microbiology. Right to pursue a doctoral degree Please note that the appointee must obtain the right to pursue a doctoral degree at the Faculty of Pharmacy, University of Helsinki and approval by a suitable doctoral programme (Doctoral Programme in Drug Research - DPDR) by the end of the standard 6-month probationary period of the employment, unless having already existing study right. The research plan and other application material will be prepared together with the PhD supervisor(s) in the beginning of the employment period. Salary and Benefits Salary, pension and terms of employment are in accordance with the requirements from the European Commission related to the MSCA programme. The salary (monthly living allowance) is 3 639,84 € per month before taxes. Additionally, a monthly mobility allowance 546,15 € per month before taxes will be paid. If applicable, a conditional monthly family allowance of 507,69 € per month before taxes are paid. The guaranteed PhD funding is for 36 months (i.e., funding from the European Commission). In addition to their individual scientific projects, all DCs will benefit from further education, including secondments to Technion Research and Development Foundation Ltd., Image Guided Therapy and CIC biomaGUNE, a variety of training modules as well as transferable skills courses and active participation in workshops and conferences. Standard Finnish pension benefits and occupational health care are provided for University of Helsinki employees. Read more about the employee benefits at the University of Helsinki and why the University of Helsinki is an excellent career choice: https://www.helsinki.fi/en/about-us/careers. Please also see about relocation support: https://www.helsinki.fi/en/about-us/careers/welcome-finland-information-arriving-staff. How to apply Please submit your application, together with the required attachments AS A SINGLE PDF FILE (in the CV section), through the University of Helsinki Recruitment System via the button Apply now (or Employee login). The application must contain the following documents AS A SINGLE PDF FILE (all provided in English language): INTRABRAIN DC application form (download template here: https://www.intrabrain.eu/s/INTRABRAIN_DC_application-form_final.docx) Curriculum Vitae (max 2 pages) Cover letter (max 1 page): Indicate your motivation to apply for these specific DC position and your skills that are specifically adapted to the chosen topic, providing support evidence to your arguments. Certificate of Master’s Degree (or equivalent) with transcript of records. Proof of English proficiency Contact details of 2 previous supervisors or employers who can give recommendation letters List of publications, if applicable. Manuscript of listed publication, if applicable. Work/research experience certificates, if applicable. All official certificates should be provided in their original European language or associated official English translation for non-European documents. If you are applying for a country different from your native country, an English supplement of the certificates with transcripts should also be provided. Application deadline is on the 28 of May 2026 at 23:59 (Europe/Helsinki time). Further information on: The INTRABRAIN project and the open positions on INTRABRAIN website: https://www.intrabrain.eu/ ImmunoViroTherapy Lab: https://www.helsinki.fi/en/researchgroups/immunovirotherapy-lab The project and position: Professor Vincenzo Cerullo, vincenzo.cerullo@helsinki.fi Technical support in applying: HR Specialist Heidi Kauppinen, recruitment(@helsinki.fi Faculty of Pharmacy: https://www.helsinki.fi/en/faculty-of-pharmacy Viikki Campus: https://www.helsinki.fi/en/about-us/campuses/viikki-campus Working at the University of Helsinki: https://www.helsinki.fi/en/about-us/careers  Support for international staff: https://www.helsinki.fi/en/about-us/careers/welcome-finland-information-arriving-staff and International House Helsinki: https://ihhelsinki.fi Application process to doctoral education at the University of Helsinki: https://www.helsinki.fi/en/admissions-and-education/apply-doctoral-programmes/how-apply-doctoral-programmes (includes also information on accepted ways of proving language skills, when applying to doctoral education; specific research plan and other doctoral application material will be prepared together with the PhD supervisor(s) if selected to this position) This project is funded by the European Union (INTRABRAIN, 101227308). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. The Faculty of Pharmacy at the University of Helsinki provides the highest education in the field of pharmacy offers undergraduate degrees in Bachelor of Science (Pharmacy), Master of Science (Pharmacy), Master of Science, and doctoral degrees (Doctor of Philosophy in Pharmacy, Doctor of Philosophy). offers specialization studies in community and hospital pharmacy, and industrial pharmacy is located at Viikki Campus in Helsinki and provides access to local and national research infrastructures has about 200 employees, out of which about 20 are professors has 900 undergraduate students and 140 doctoral researchers  hosts the multidisciplinary Drug Research Program and the Doctoral Programme in Drug Research  is a European and global leader in sustainable pharmacy is a member of the ULLA consortium (European University Consortium for Pharmaceutical Sciences) Why Finland and Helsinki Finland is a member of the EU, has high-quality and inexpensive childcare, free schooling and tertiary training (also in English), excellent family benefits and healthcare, and is ranked as one of the top countries in the world for expat families. Finland also repeatedly tops the World Happiness Report.  Why Finland is a great place to live and work: https://www.helsinki.fi/en/about-us/careers/why-university-helsinki/why-finland  10 reasons to work in Helsinki: https://www.helsinki.fi/en/about-us/careers/why-university-helsinki/why-helsinki  Welcome to Helsinki: https://welcome.helsinki  A diverse and equitable study and work culture is important to us. That is why we do our best to promote an inclusive university community. We encourage all qualified applicants from diverse backgrounds to apply for our positions. Click this link to read about accessibility and inclusivity at our University. JOIN US TO BUILD A BETTER WORLD – TOGETHER! #HelsinkiUniCareers

Department: Office: VP Students and Learning Vacancy ID: 041323 Closing Date: 17-May-2026 Maynooth University is committed to a strategy in which the primary University goals of excellent research and scholarship and outstanding education are interlinked and equally valued. We are seeking a student‑centred, collaborative and impact-driven Student Success Officer committed to advancing partnership and belonging across the University. The postholder will play a central role in embedding and advancing a culture of student partnership, and belonging across Maynooth University. Building on the work of the Thrive student success initiative, the role will support institution-wide approaches that strengthen student transitions and dialogue, ensuring that student feedback informs ongoing enhancements to the student experience. Working within Student Skills and Success, the postholder will collaborate closely with students, the Maynooth Students’ Union, academic colleagues, and professional services to ensure that student voice, belonging, and partnership are embedded across the student lifecycle. Administrative Officer I: €59,812– €85,339 p.a. (9 points) Appointments will be made in accordance with public sector pay provisions. Closing Date: 23:30hrs (local Irish time) on Sunday, 17th of May 2026. Applications must be submitted by the closing date and time specified above. Any applications which are still in progress at the closing time on the specified closing date will be cancelled automatically by the system. Late applications will not be accepted. Maynooth University is an equal opportunities employer The position is subject to the Statutes of the University